...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Monocyte‐Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function
【24h】

Monocyte‐Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function

机译:C /EBPα的单核细胞特异性敲除导致骨质异步表型,阻断卵巢切除小鼠的骨质损失,并揭示了骨骨细胞分化和功能中C /EBPα的重要功能

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT CCAAT/enhancer‐binding protein α (C/ebpα) is critical for osteoclastogenesis by regulating osteoclast (OC) lineage commitment and is also important for OC differentiation and function in vitro. However, the role of C/ebpα in postnatal skeletal development has not been reported owing to lethality in C/ebpα –/– mice from hypoglycemia within 8 hours after birth. Herein, we generated conditional knockout mice by deleting the C/ebpα gene in monocyte via LysM‐Cre to examine its role in OC differentiation and function. C/ebpα f/f LysM‐Cre mice exhibited postnatal osteopetrosis due to impaired osteoclastogenesis, OC lineage priming defects, as well as defective OC differentiation and activity. Furthermore, our ex vivo analysis demonstrated that C/ebpα conditional deletion significantly reduced OC differentiation, maturation, and activity while mildly repressing macrophage development. At the molecular level, C/ebpα deficiency significantly suppresses the expressions of OC genes associated with early stages of osteoclastogenesis as well as genes associated with OC differentiation and activity. We also identified numerous C/ebpα critical cis‐regulatory elements on the Cathepsin K promoter that allow C/ebpα to significantly upregulate Cathepsin K expression during OC differentiation and activity. In pathologically induced mouse model of osteoporosis, C/ebpα deficiency can protect mice against ovariectomy‐induced bone loss, uncovering a central role for C/ebpα in osteolytic diseases. Collectively, our findings have further established C/ebpα as a promising therapeutic target for bone loss by concurrently targeting OC lineage priming, differentiation, and activity. ? 2017 American Society for Bone and Mineral Research.
机译:摘要CCAAT /增强剂结合蛋白α(C /EBPα)通过调节骨酸(OC)谱系承诺,对OC分化和体外功能也很重要。然而,由于在出生后8小时内的低血糖中的C /EBPα - / - 小鼠的致死性,C /EBPα在出生后骨骼发育中的作用尚未报告。在此,通过Lysm-CRE删除单核细胞中的C /EBPα基因通过Lysm-Cre删除其在OC分化和功能中的作用来产生条件敲除小鼠。 C /EBPαf/ f Lysm-Cre小鼠由于骨骨细胞发生受损,OC谱系引发缺陷以及缺陷的OC分化和活性而表现出产前骨质术速率。此外,我们的前体内分析表明C /EBPα有条件缺失显着降低了OC分化,成熟和活性,同时轻度压制巨噬细胞发育。在分子水平下,C /EBPα缺乏显着抑制与骨质细胞发生的早期阶段相关的OC基因的表达以及与oc分化和活性相关的基因。我们还鉴定了在组织蛋白酶K启动子上鉴定了众多C /EBPα关键顺式CIS-调节元件,其允许C /EBPα在oc分化和活性期间显着上调组织蛋白酶K表达。在病理诱导的骨质疏松症的小鼠模型中,C /EBPα缺乏可以保护小鼠免受卵巢切除诱导的骨质损失,揭示骨溶解疾病中C /EBPα的核心作用。通过同时靶向OC谱系引发,分化和活性,集体,我们的研究结果进一步建立了C /EBPα作为骨质损失的有希望的治疗靶标。还2017年美国骨骼和矿物学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号